
Ascendis Pharma (ASND) Earnings Dates & Reports
Ascendis Pharma (ASND) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS-$0.06
Actual EPS-$0.64
EarningsMiss
Ascendis Pharma (ASND) Earnings
View the latest Ascendis Pharma (ASND) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Ascendis Pharma (ASND)
Order type
Buy in
Order amount
Est. shares
0 shares
Ascendis Pharma (ASND) Earnings per Share (EPS) History
Signup for full accessBrowse free
Ascendis Pharma (ASND) Latest Earnings
The value each ASND share was expected to gain vs. the value each share gained.
Ascendis Pharma (ASND) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$0.64. This exceeded analysts' expectations of -$0.06 by 966.67%, marking a Miss.
For comparison, Ascendis Pharma reported EPS of -$0.68 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.48.
Ascendis Pharma (ASND) Earnings History
Ascendis Pharma (ASND) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Ascendis Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Ascendis Pharma (ASND) Earnings FAQs
Ascendis Pharma (ASND) last reported earnings on Feb 11, 2026 for Q4 2025, posting an EPS of -$0.64, which Miss the estimate of -$0.06 by 966.67%.
For Q4 2025, Ascendis Pharma (ASND) reported an EPS of -$0.64, missing analysts' estimate of -$0.06 by 966.67%.
For Q4 2025, Ascendis Pharma (ASND) Miss expectations with an actual EPS of -$0.64 vs. an estimated EPS of -$0.06.
Following the last earnings report on Feb 11, 2026, Ascendis Pharma (ASND)'s stock price moved — from — to —.
The next Ascendis Pharma (ASND) earnings call is scheduled for Apr. 30, 2026, where executives will discuss financial results and outlook.